Influence of chronic autoimmune thyroiditis and papillary thyroid cancer on serum calcitonin levels

Thyroid

Volumn 23, Issue 6, 2013, Pages 671-674

  Rosario, Pedro Weslley ^a,b   Calsolari, Maria Regina ^b  

^a Postgraduate Program of Santa Casa   (Brazil)

^b Endocrinology Service   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; BIOLOGICAL MARKER;

ARTICLE; CALCITONIN BLOOD LEVEL; COMPARATIVE STUDY; DISTANT METASTASIS; FEMALE; HASHIMOTO DISEASE; HISTOLOGY; HUMAN; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; ULTRASOUND; AUTOIMMUNE THYROIDITIS; BLOOD; CARCINOMA; COMPLICATION; ECHOGRAPHY; FAMILY HEALTH; PATHOLOGY; SECRETION (PROCESS); SIBLING; THYROID GLAND; THYROID NODULE; THYROID TUMOR; TUMOR VOLUME; UPREGULATION;

BIOLOGICAL MARKERS; CALCITONIN; CARCINOMA; FAMILY HEALTH; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; SIBLINGS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDITIS, AUTOIMMUNE; TUMOR BURDEN; UP-REGULATION;

EID: 84878832755     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0564     Document Type: Article

References (25)

1. Paschke R, Hegedüs L, Alexander E, Valcavi R, Papini E, Gharib H 2011 Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol 6:354-361.
2. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126.
3. Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE 2009 Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (São Paulo) 64:699-706.
4. Rosario PW, Mineiro Filho AF, Prates BS, Silva LC, Lacerda RX, Calsolari MR 2012 Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma. Thyroid 22:805-808.
5. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grünwald F 2009 Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327-332.
6. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168.
7. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455.
8. Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R, Bigorgne JC 1991 Chronic autoimmune thyroiditis and Ccell hyperplasia. Study of calcitonin secretion in 24 patients. Ann Endocrinol (Paris) 52:109-112.
9. Guyetant S, Wion-Barbot N, Rousselet MC, Franc B, Bigorgne JC, Saint-Andre JP 1994 C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. Hum Pathol 25:514-521.
10. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, Niederle B, Dudczak R, Pirich C 2004 Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89:515-519.
11. Pantazi H, Papapetrou PD 1998 Calcitonin levels are similar in goitrous euthyroid patients with or without thyroid antibodies, as well as in hypothyroid patients. Eur J Endocrinol 138:530-535.
12. Grani G, Nesca A, Del Sordo M, Calvanese A, Carbotta G, Bianchini M, Fumarola A 2012 Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis. Endocr Relat Cancer 19:345-349.
13. Kratzsch J, Petzold A, Raue F, Reinhardt W, Bröcker-Preuss M, Görges R, Mann K, Karges W, Morgenthaler N, Luster M, Reiners C, Thiery J, Dralle H, Fuhrer D 2011 Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57:467-474.
14. Lima MA, Santos BM, Borges MF 1998 Quantitative analysis of C cells in Hashimoto's thyroiditis. Thyroid 8:505-509.
15. Borges MF, Abelin NM, Menezes FO, Dahia PL, Toledo SP 1998 Calcitonin deficiency in early stages of chronic autoimmune thyroiditis. Clin Endocrinol (Oxf) 49:69-75.
16. Poppe K, Verbruggen LA, Velkeniers B, Finné E, Body JJ, Vanhaelst L 1999 Calcitonin reserve in different stages of atrophic autoimmune thyroiditis. Thyroid 9:1211-1214.
17. Body JJ, Demeester-Mirkine N, Borkowski A, Suciu S, Corvilain J 1986 Calcitonin deficiency in primary hypothyroidism. J Clin Endocrinol Metab 62:700-703.
18. Sadow PM, Hunt JL 2010 Mixed medullary-follicularderived carcinomas of the thyroid gland. Adv Anat Pathol 17:282-285.
19. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829.
20. Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, Fadda G, Baldini A, Carani C, Pontecorvi A, Roti E 2006 Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29: 427-437.
21. Niccoli P, Wion-Barbot N, Caron P, Henry JF, De Micco E, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 82:338-341.
22. Henry JF, Denizot A, Puccini M, Gramatica L, Kvachenyuk A, Conte Devolx B, De Micco C 1998 Latent subclinical medullary thyroid carcinoma: diagnosis and treatment. World J Surg 22:752-756.
23. Iacobone M, Niccoli-Sire P, Sebag F, DeMicco C, Henry JF 2002 Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 26:886-890.
24. Herrmann BL, Schmid KW, Goerges R, Kemen M, Mann K 2010 Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol 162:1141-1145.
25. Schneider C, Kobe C, Schmidt M, Kahraman D, Malchau G, Faust M, Schicha H, Dietlein M 2012 Calcitonin screening in patients with thyroid nodules. Diagnostic value. Nuklearmedizin 51:228-233.